{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:49:51Z","timestamp":1765486191612},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T00:00:00Z","timestamp":1520553600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12883-018-1013-8","type":"journal-article","created":{"date-parts":[[2018,3,9]],"date-time":"2018-03-09T02:26:08Z","timestamp":1520562368000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Glutathione S-transferase M1 and T1 polymorphisms and the risk of mild hepatotoxicity induced by carbamazepine in a tunisian population study"],"prefix":"10.1186","volume":"18","author":[{"given":"Chahra","family":"Chbili","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anis","family":"Hassine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neila","family":"Fathallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manel","family":"Nouira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salma","family":"Naija","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofiene","family":"Ben Ammou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saad","family":"Saguem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,9]]},"reference":[{"issue":"6","key":"1013_CR1","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1007\/s00216-006-0724-7","volume":"386","author":"O Ek","year":"2006","unstructured":"Ek O, Ban E, Woo JS, Kim CK. Analysis of carbamazepine and its active metabolite, carbamazepine-10,11-epoxide, in human plasma using high-performance liquid chromatography. Anal Bioanal Chem. 2006;386(6):1931\u20136.","journal-title":"Anal Bioanal Chem"},{"issue":"3","key":"1013_CR2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1056\/NEJM199601183340308","volume":"334","author":"MJ Brodie","year":"1996","unstructured":"Brodie MJ, Dichter M. Antiepileptic drugs. N Engl J Med. 1996;334(3):168\u201375.","journal-title":"N Engl J Med"},{"issue":"3","key":"1013_CR3","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/BF03256188","volume":"21","author":"MP Kalapos","year":"2002","unstructured":"Kalapos MP. Carbamazepine-provoked hepatotoxicity and possible aetiopathological role of glutathione in the events. Retrospective review of old data and call for new investigation. Adverse Drug React Toxicol Rev. 2002;21(3):123\u201341.","journal-title":"Adverse Drug React Toxicol Rev"},{"key":"1013_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1528-1157.2000.tb02945.x","volume":"41","author":"CL Harden","year":"2000","unstructured":"Harden CL. Therapeutic safety monitoring: what to look for and when to look for it. Epilepsia. 2000;41:37\u201344.","journal-title":"Epilepsia"},{"issue":"11","key":"1013_CR5","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1124\/dmd.30.11.1170","volume":"30","author":"RE Pearce","year":"2002","unstructured":"Pearce RE, Vakkalagadda GR, Leeder JS. Pathways of carbamazepine bioactivation in vitro I. Characterization of human cytochromes P450 responsible for the formation of 2- and 3-hydroxylated metabolites. Drug Metab Dispos. 2002;30(11):1170\u20139.","journal-title":"Drug Metab Dispos"},{"key":"1013_CR6","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jchromb.2005.09.019","volume":"828","author":"H Breton","year":"2005","unstructured":"Breton H, Cociglio M, Bressolle F, Peyriere H, Blayac JP, Hillaire-Buys D. Liquid chromatography-electrospray mass spectrometry determination of carbamazepine, oxcarbazepine and eight of their metabolites in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 2005;828:80\u201390.","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"1013_CR7","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1124\/dmd.105.005413","volume":"33","author":"HZ Bu","year":"2005","unstructured":"Bu HZ, Kang P, Deese AJ, Zhao P, Pool WF. Human in vitro glutathionyl and protein adducts of carbamazepine-10,11-epoxide, a stable and pharmacologically active metabolite of carbamazepine. Drug Metab Dispos. 2005;33:1920\u20134.","journal-title":"Drug Metab Dispos"},{"key":"1013_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2165\/00003088-198611030-00001","volume":"11","author":"L Bertilsson","year":"1986","unstructured":"Bertilsson L, Tomson T. Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine-10,11-epoxide. An update. Clin Pharmacokinet. 1986;11:177\u201398.","journal-title":"Clin Pharmacokinet"},{"key":"1013_CR9","first-page":"29","volume-title":"Principles and methods of toxicology","author":"JD DeBethizy","year":"1988","unstructured":"DeBethizy JD, Hayes JR. Metabolism. A determinant of toxicity. In: Hayes AW, editor. Principles and methods of toxicology. 2nd ed. New York: Raven Press; 1988. p. 29\u201366.","edition":"2"},{"key":"1013_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev.pharmtox.45.120403.095857","volume":"45","author":"JD Hayes","year":"2005","unstructured":"Hayes JD, Flanagan JU, Jowsey IR. Glutathione transferases. Annu Rev Pharmacol Toxicol. 2005;45:51\u201388.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1013_CR11","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s00432-003-0439-5","volume":"129","author":"M Munaka","year":"2003","unstructured":"Munaka M, Kohshi K, Kawamoto T, Takasawa S, Nagata N, Itoh H, Oda S, Katoh T. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinoma. J Cancer Res Clin Oncol. 2003;129:355\u201360.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1013_CR12","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1093\/carcin\/15.5.1077","volume":"15","author":"HJ Lin","year":"1994","unstructured":"Lin HJ, Han CY, Bernstein DA, Hsiao W, Lin BK, Hardy S. Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility. Carcinogenesis. 1994;15:1077\u201381.","journal-title":"Carcinogenesis"},{"issue":"2","key":"1013_CR13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1093\/toxsci\/49.2.156","volume":"49","author":"DL Eaton","year":"1999","unstructured":"Eaton DL, Bammler TK. Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol Sci. 1999;49(2):156\u201364.","journal-title":"Toxicol Sci"},{"issue":"1","key":"1013_CR14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.7326\/0003-4819-95-1-64","volume":"95","author":"M Levy","year":"1981","unstructured":"Levy M, Goodman MW, Van Dyne BJ, Sumner HW. Granulomatous hepatitis secondary to carbamazepine. Ann Intern Med. 1981;95(1):64\u20135.","journal-title":"Ann Intern Med"},{"key":"1013_CR15","first-page":"10","volume":"475","author":"D L\u00e9vy-Chavagnat","year":"2008","unstructured":"L\u00e9vy-Chavagnat D. Strat\u00e9gies de traitement des syndromes \u00e9pileptiques. Actual Pharm. 2008;475:10\u20136.","journal-title":"Actual Pharm"},{"key":"1013_CR16","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.eplepsyres.2014.05.009","volume":"108","author":"C Chbili","year":"2014","unstructured":"Chbili C, B'chir F, Ben Fredj M, Saguem BN, Ben Amor S, Ben Ammou S, Saguem S. Effects of glutathione S-transferase M1 and T1 deletions on epilepsy risk among a Tunisian population. Epilepsy Res. 2014a;108:1168\u201373.","journal-title":"Epilepsy Res"},{"key":"1013_CR17","first-page":"453","volume":"72","author":"C Chbili","year":"2014","unstructured":"Chbili C, Bannour S, Khlifi S, Ben Hadj Ali B, Saguem S. Relationships between pharmacokinetic parameters of carbamazepine and therapeutic response in patients with bipolar disease. Ann Biol Clin (Paris). 2014b;72:453\u20139.","journal-title":"Ann Biol Clin (Paris)"},{"issue":"10","key":"1013_CR18","first-page":"700","volume":"88","author":"S Gara","year":"2010","unstructured":"Gara S, Abessi M, Bendjemena K, Abdennebi M, Guemira F. Deletion polymorphism of glutathione S-transferases M1 and T1 in the Tunisian population. Tunis Med. 2010;88(10):700\u20132.","journal-title":"Tunis Med"},{"issue":"5","key":"1013_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1155\/2011\/796520","volume":"31","author":"AH Salem","year":"2011","unstructured":"Salem AH, Yaqoob A, Ali M, Handu S, Fadel R, Abu-Hijleh M, Almawi W. Genetic polymorphism of the glutathione S-transferase M1 and T1 genes in three distinct Arab populations. Dis Markers. 2011;31(5):311\u20136.","journal-title":"Dis Markers"},{"key":"1013_CR20","doi-asserted-by":"publisher","first-page":"435","DOI":"10.2217\/14622416.8.5.435","volume":"8","author":"K Ueda","year":"2007","unstructured":"Ueda K, Ishitsu T, Seo T, Ueda N, Murata T, Hori M, Nakagawa K. Glutathione S-transferase M1 null genotype as a risk factor for carbamazepine-induced mild hepatotoxicity. Pharmacogenomics. 2007;8:435\u2013842.","journal-title":"Pharmacogenomics"},{"issue":"3","key":"1013_CR21","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.psychres.2010.10.008","volume":"187","author":"P Gravina","year":"2011","unstructured":"Gravina P, Spoletini I, Masini S, Valentini A, Vanni D, Paladini E, Boss\u00f9 P, Caltagirone C, Federici G, Spalletta G, Bernardini S. Genetic polymorphisms of glutathione S-transferases GSTM1, GSTT1, GSTP1and GSTA1 as risk factors for schizophrenia. Psychiatry Res. 2011;187(3):454\u20136.","journal-title":"Psychiatry Res"},{"key":"1013_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/oxfordjournals.aje.a010124","volume":"151","author":"SC Cotton","year":"2000","unstructured":"Cotton SC, Sharp L, Little J, Brockton N. GlutathioneS-transferase polymorphisms and colorectal cancer: a HuGE review. Am J Epidemiol. 2000;151:7\u201332.","journal-title":"Am J Epidemiol"},{"key":"1013_CR23","first-page":"15","volume":"62","author":"M Habdous","year":"2004","unstructured":"Habdous M, Siest G, Herbeth B, Vincent-Viry M, Visvikis S. Polymorphismes des glutathion S-transf\u00e9rases et pathologies humaines: bilan des \u00e9tudes \u00e9pid\u00e9miologiques. Ann Biol Clin. 2004;62:15\u201324.","journal-title":"Ann Biol Clin"},{"issue":"1\u20132","key":"1013_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.mrgentox.2008.09.009","volume":"674","author":"NJ Martin","year":"2009","unstructured":"Martin NJ, Collier AC, Bowen LD, Pritsos KL, Goodrich GG, Arger K, Cutter G, Pritsos CA. Polymorphisms in the NQO1, GSTT and GSTM genes are associated with coronary heart disease and biomarkers of oxidative stress. Mutat Res. 2009;674(1\u20132):93\u2013100.","journal-title":"Mutat Res"},{"key":"1013_CR25","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/0006-2952(92)90696-G","volume":"43","author":"M Pirmohamed","year":"1992","unstructured":"Pirmohamed M, Kitteringham NR, Guenthner TM, Breckenridge AM, Park BK. An investigation of the formation of cytotoxic, protein-reactive and stable metabolites from carbamazepine in vitro. Biochem Pharmacol. 1992;43:1675\u201382.","journal-title":"Biochem Pharmacol"},{"issue":"9","key":"1013_CR26","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1046\/j.1440-1746.2001.02585.x","volume":"16","author":"B Roy","year":"2001","unstructured":"Roy B, Chowdhury A, Kundu S, Santra A, Dey B, Chakraborty M, Majumder PP. Increased risk of antituberculosis drug \u2013induced hepatotoxicity in individuals with glutathione S-transferase M1 null mutation. J Gastroenterol Hepatol. 2001;16(9):1033\u20137.","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"1013_CR27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0009-9236(03)00014-6","volume":"73","author":"I Watanabe","year":"2003","unstructured":"Watanabe I, Tomita A, Shimizu M, Sugawara M, Yasumo H, Koishi R, Takahashi T, Miyoshi K, Nakamura K, Izumi T, Matsushita Y, Furukawa H, Haruyama H, Koga T. A study to survey susceptible genetic factors responsible for troglitazone- associated hepatotoxicity in Japanes patients with type 2 diabetes mellitus. Clin Pharmaco Ther. 2003;73(5):435\u201355.","journal-title":"Clin Pharmaco Ther"},{"issue":"4","key":"1013_CR28","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1067\/mcp.2000.104944","volume":"67","author":"T Simon","year":"2000","unstructured":"Simon T, Becquemont L, Mary-Krause M, de Waziers I, Beaune P, Funck-Brentano C, Jaillon P. Combined glutathione s-transferases M1 and T1 genetic polymorphism and tacrine hepatotoxicity. Clin Pharmacol Ther. 2000;67(4):432\u20137.","journal-title":"Clin Pharmacol Ther"},{"issue":"12","key":"1013_CR29","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s13258-015-0330-1","volume":"37","author":"C Chbili","year":"2015","unstructured":"Chbili C, Fathallah N, Nouira M, Laouani A, Hassine A, Ben Amor S, Ben Ammou S, Saguem S. Effects of glutathione S-transferase M1 and T1 deletions on carbamazepine metabolism among a Tunisian population. Genes Genomics. 2015;37(12):991\u20137.","journal-title":"Genes Genomics"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-018-1013-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-018-1013-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-018-1013-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T19:17:09Z","timestamp":1552072629000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-018-1013-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,9]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1013"],"URL":"https:\/\/doi.org\/10.1186\/s12883-018-1013-8","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,9]]},"assertion":[{"value":"13 April 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the local ethical committee. A written Informed consent was obtained from each study participant before interview and blood collection for genetic analyses. For those under the age of 18, a consent was obtained from their parents.All information regarding the participants was made anonymous after the collection of the data and blood samples.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"24"}}